Advanced oxidation protein products inhibit the autophagy of renal tubular epithelial cells

Zhang,Jun; Xiang,Xiaohong; Shu,Shuangshuang; Zhang,Cuiling; Liang,Yuling; Jiang,Tingting; Zhang,Wenying; Guo,Tingting; Liang,Xiujie; Tang,Xun

doi:10.3892/etm.2018.5875

Advanced oxidation protein products inhibit the autophagy of renal tubular epithelial cells

Authors:
- Jun Zhang
- Xiaohong Xiang
- Shuangshuang Shu
- Cuiling Zhang
- Yuling Liang
- Tingting Jiang
- Wenying Zhang
- Tingting Guo
- Xiujie Liang
- Xun Tang
View Affiliations

Affiliations: Department of Nephrology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510280, P.R. China
Published online on: February 15, 2018 https://doi.org/10.3892/etm.2018.5875
Pages: 3908-3916
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It is well known that autophagy serves a crucial role in renal tubular epithelial cell (RTEC) injury in the pathogenesis of chronic kidney disease (CKD). The accumulation of advanced oxidation protein products (AOPPs) also participates in the progression of CKD. However, the effects of AOPPs on autophagy remain unknown. To clarify the underlying mechanism of RTEC injury in CKD, the effect of AOPPs on HK‑2 cells, an RTEC cell line, was investigated. The results of the present study revealed that AOPP exposure downregulated the expression of B‑cell lymphoma‑2‑interacting myosin‑like coiled‑coil protein 1, reduced the conversion of microtubule‑associated proteins 1 light chain 3B (LC3)‑I to LC3‑II and the formation of autophagosomes, and lead to an accumulation of p62. These results suggest that AOPPs may inhibit the autophagic activity of HK‑2 cells. Furthermore, the aforementioned changes were mediated by the AOPP‑phosphorylated phosphoinositide 3‑kinase3‑kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway; this was verified by treatment with LY294002, a PI3K inhibitor, which reversed the AOPP‑induced changes. The present study also demonstrated that the activation of autophagy with rapamycin led to an improvement in the AOPP‑induced overexpression of kidney injury molecule 1 and neutrophil gelatinase‑associated lipocalin, two biomarkers of RTEC injury, whereas inhibiting autophagy with chloroquine further increased their expression during AOPP treatment. Collectively, these results indicate that AOPPs may inhibit autophagy in RTECs via activation of the PI3K/AKT/mTOR pathway and that autophagy inhibition serves a role in AOPP-induced RTEC injury.

View Figures

View References

1	Couser WG, Remuzzi G, Mendis S and Tonelli M: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 80:1258–1270. 2011. View Article : Google Scholar : PubMed/NCBI
2	Eddy AA: Progression in chronic kidney disease. Adv Chronic Kidney Dis. 12:353–365. 2005. View Article : Google Scholar : PubMed/NCBI
3	Grgic I, Campanholle G, Bijol V, Wang C, Sabbisetti VS, Ichimura T, Humphreys BD and Bonventre JV: Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 82:172–183. 2012. View Article : Google Scholar : PubMed/NCBI
4	Huber TB, Edelstein CL, Hartleben B, Inoki K, Jiang M, Koya D, Kume S, Lieberthal W, Pallet N, Quiroga A, et al: Emerging role of autophagy in kidney function, diseases and aging. Autophagy. 8:1009–1031. 2012. View Article : Google Scholar : PubMed/NCBI
5	Levine B and Klionsky DJ: Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
6	Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
7	Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y: Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 6:1221–1228. 2004. View Article : Google Scholar : PubMed/NCBI
8	Mizushima N: Autophagy: Process and function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
9	Bjorkoy G, Lamark T, Pankiv S, Øvervatn A, Brech A and Johansen T: Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 452:181–197. 2009. View Article : Google Scholar : PubMed/NCBI
10	Yang C, Kaushal V, Shah SV and Kaushal GP: Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol. 294:F777–F787. 2008. View Article : Google Scholar : PubMed/NCBI
11	Suzuki C, Isaka Y, Takabatake Y, Tanaka H, Koike M, Shibata M, Uchiyama Y, Takahara S and Imai E: Participation of autophagy in renal ischemia/reperfusion injury. Biochem Biophys Res Commun. 368:100–106. 2008. View Article : Google Scholar : PubMed/NCBI
12	Liu WJ, Luo MN, Tan J, Chen W, Huang LZ, Yang C, Pan Q, Li B and Liu HF: Autophagy activation reduces renal tubular injury induced by urinary proteins. Autophagy. 10:243–256. 2014. View Article : Google Scholar : PubMed/NCBI
13	Huang C, Lin MZ, Cheng D, Braet F, Pollock CA and Chen XM: Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux. Lab Invest. 94:309–320. 2014. View Article : Google Scholar : PubMed/NCBI
14	Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P and Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:1304–1313. 1996. View Article : Google Scholar : PubMed/NCBI
15	Kalousová M, Skrha J and Zima T: Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res. 51:597–604. 2002.PubMed/NCBI
16	Zhou LL, Hou FF, Wang GB, Yang F, Xie D, Wang YP and Tian JW: Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int. 76:1148–1160. 2009. View Article : Google Scholar : PubMed/NCBI
17	Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, et al: Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol. 18:528–538. 2007. View Article : Google Scholar : PubMed/NCBI
18	Tang X, Rong G, Bu Y, Zhang S, Zhang M, Zhang J and Liang X: Advanced oxidation protein products induce hypertrophy and epithelial-to-mesenchymal transition in human proximal tubular cells through induction of endoplasmic reticulum stress. Cell Physiol Biochem. 35:816–828. 2015. View Article : Google Scholar : PubMed/NCBI
19	Yang YP, Liang ZQ, Gu ZL and Qin ZH: Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin. 26:1421–1434. 2005. View Article : Google Scholar : PubMed/NCBI
20	Lieberthal W and Levine JS: The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol. 20:2493–2502. 2009. View Article : Google Scholar : PubMed/NCBI
21	Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J and Pedraza-Chaverri J: The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 26:2694–2701. 2014. View Article : Google Scholar : PubMed/NCBI
22	Satriano J and Sharma K: Autophagy and metabolic changes in obesity-related chronic kidney disease. Nephrol Dial Transplant. 28 Suppl 4:S29–S36. 2013. View Article : Google Scholar
23	Lieberthal W and Levine JS: Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications. Am J Physiol Renal Physiol. 303:F180–F191. 2012. View Article : Google Scholar : PubMed/NCBI
24	Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T and Descamps-Latscha B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 161:2524–2532. 1998.PubMed/NCBI
25	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C-T method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
26	Caplin B and Nitsch D: Urinary biomarkers of tubular injury in chronic kidney disease. Kidney Int. 91:21–23. 2017. View Article : Google Scholar : PubMed/NCBI
27	Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
28	Boya P, Reggiori F and Codogno P: Emerging regulation and functions of autophagy. Nat Cell Biol. 15:713–720. 2013. View Article : Google Scholar : PubMed/NCBI
29	Mavroeidi V, Petrakis I, Stylianou K, Katsarou T, Giannakakis K, Perakis K, Vardaki E, Stratigis S, Ganotakis E, Papavasiliou S and Daphnis E: Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy. J Histochem Cytochem. 61:433–443. 2013. View Article : Google Scholar : PubMed/NCBI
30	Wang Z and Choi ME: Autophagy in kidney health and disease. Antioxid Redox Signal. 20:519–537. 2014. View Article : Google Scholar : PubMed/NCBI
31	Takabatake Y, Kimura T, Takahashi A and Isaka Y: Autophagy and the kidney: Health and disease. Nephrol Dial Transplant. 29:1639–1647. 2014. View Article : Google Scholar : PubMed/NCBI
32	Yamahara K, Kume S, Koya D, Tanaka Y, Morita Y, Chin-Kanasaki M, Araki H, Isshiki K, Araki S, Haneda M, et al: Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol. 24:1769–1781. 2013. View Article : Google Scholar : PubMed/NCBI
33	Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K and Koya D: Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: A model of type 2 diabetes. Exp Diabetes Res. 2011:9081852011. View Article : Google Scholar : PubMed/NCBI
34	Huang JX, Kaeslin G, Ranall MV, Blaskovich MA, Becker B, Butler MS, Little MH, Lash LH and Cooper MA: Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: Comparison of HK-2, immortalized human proximal tubule epithelial and primary cultures of human proximal tubular cells. Pharmacol Res Perspect. 3:e001482015. View Article : Google Scholar : PubMed/NCBI